SBD Laboratories

SBD Laboratories is a biotechnology company specializing in the development of advanced cannabinoid-based therapeutics for pain management and inflammatory conditions. The company utilizes its proprietary SBD-TD transdermal delivery platform to enhance the bioavailability and controlled release of cannabinoids like CBD and THC, overcoming the limitations of oral and inhaled administration. Their lead program, SBD-101, is a transdermal patch designed to provide systemic relief for chronic and neuropathic pain through consistent, pharmaceutical-grade dosing. By applying rigorous clinical standards to naturally derived compounds, SBD Laboratories aims to bridge the gap between medical cannabis and traditional pharmaceutical therapy. The company is headquartered in Northbrook, Illinois, and continues to expand its pipeline into various neurological and rheumatological indications.